Trial Profile
Penetration of Ertapenem Into Bone in Patients With Diabetes Mellitus or Peripheral Vascular Diseases Who Underwent Bellow Knee Amputation
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 27 Jul 2007
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 12 Jul 2007 Status changed from recruiting to withdrawn prior to recruitment.
- 21 Nov 2006 New trial record.